comparemela.com
  1. Home
  2. Live Updates
  3. David Auregan - Breaking News

Latest Breaking News On - David auregan - Page 1 : comparemela.com

THERACLION: HIFU and their Use in Immune-oncology Presented at the Annual Scientific Meeting of the Society of Interventional Radiology in Boston

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for noninvasive echotherapy providing consistent, data

United statesFrance generalKostenloser wertpapierhandelDavid aureganDavid breninPatrick dillonMichel nutaAnja kleberMelanoma surgical servicesUniversity of virginiaDivision of breastDepartment of hematologySociety of interventional radiologyDepartment of surgeryRegulatory newsInterventional radiology

Theraclion Launches Its New Robotic Vein Platform SONOVEIN HD

Regulatory News: THERACLION (Paris:ALTHE) (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a scalable robotic platform for non-invasive echotherapy, announces todaythe launch

Aix en provenceProvence alpes côd azurFrance generalKostenloser wertpapierhandelDavid aureganDavid caumartinGuillaume stalnikiewiczAnja kleberRegulatory newsSupersonic imagineHigh intensity focussed ultrasoundEuronext growth parisOperating officerMarket access sales francophonia

First Patients Treated With Theraclion s SONOVEIN in the US

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a scalable robotic platform for non-invasive echotherapy, announces todaythe treatment of varicose

United statesFrance generalKostenloser wertpapierhandelDavid aureganAntonios gasparisSteven eliasMichel nutaAnja kleberNicos labropoulosDrug administrationRegulatory newsChief medical officerVice president veinsHigh intensity focussed ultrasoundEuronext growth parisOperating officer

Theraclion Announces 1,000th Treatment for Varicose Veins with SONOVEIN

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, today announced that

United statesFrance generalUnited kingdomKostenloser wertpapierhandelDavid aureganFelipe collaresAnja kleberRegulatory newsHigh intensity focused ultrasoundWhiteley clinicsVenous insufficiencyHigh intensity focussed ultrasoundEuronext growth parisVaricose vein device market studyOperating officerMarket access sales francophonia

THERACLION: 2021 Results in Line with Theraclion s Development Strategy for 2022

Regulatory News: THERACLION (Paris:ALTHE) (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, today released its

United statesFrance generalYann duchesneKostenloser wertpapierhandelDavid aureganAnja kleberRegulatory newsExecutive chairmanHigh intensity focussed ultrasoundEuronext growth parisOperating officerMarket access sales francophonia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.